English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 24 Help

Selected(0)Clear Items/Page:    Sort:
Exploring casual effects and shared molecular mechanism between psoriasis and liver cancer through Mendelian randomization and comprehensive bioinformatic analyses Journal article
Ran, Maoxin, Sha, Ou, Tam, Kin Yip. Exploring casual effects and shared molecular mechanism between psoriasis and liver cancer through Mendelian randomization and comprehensive bioinformatic analyses[J]. Computational Biology and Chemistry, 2024, 110, 108089.
Authors:  Ran, Maoxin;  Sha, Ou;  Tam, Kin Yip
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:2.6/2.6 | Submit date：2024/05/16
Causal Relationship  Gene Signature  Liver Cancer  Psoriasis  Rank Conservation  Shared Molecular Mechanism  
Single cell analyses of cancer cells identified two regulatorily and functionally distinct categories in differentially expressed genes among tumor subclones Journal article
Cao, Wei, Wang, Xuefei, Luo, Kaiwen, Li, Yang, Sun, Jiahong, Fu, Ruqing, Zhang, Qi, Hong, Ni, Cheung, Edwin, Jin, Wenfei. Single cell analyses of cancer cells identified two regulatorily and functionally distinct categories in differentially expressed genes among tumor subclones[J]. Heliyon, 2024, 10(6), e28071.
Authors:  Cao, Wei;  Wang, Xuefei;  Luo, Kaiwen;  Li, Yang;  Sun, Jiahong; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.4/3.9 | Submit date：2024/04/02
Colorectal Cancer  Single Cell Rna Sequencing  Single Cell Whole Genome Sequencing  Copy Number Variations  Differentially Expressed Gene  Cell-cell Communication  
PhotoPyro-Induced cGAS-STING Pathway Activation Enhanced Anti-Melanoma Immunotherapy via a Manganese-Coordinated Nanomedicine Journal article
Feng, Yuzhao, Wang, Guohao, Li, Wenxi, Yan, Jie, Yu, Xinying, Tian, Hao, Li, Bei, Dai, Yunlu. PhotoPyro-Induced cGAS-STING Pathway Activation Enhanced Anti-Melanoma Immunotherapy via a Manganese-Coordinated Nanomedicine[J]. Advanced Healthcare Materials, 2024, 13(6), 2302811.
Authors:  Feng, Yuzhao;  Wang, Guohao;  Li, Wenxi;  Yan, Jie;  Yu, Xinying; et al.
Favorite | TC[WOS]:4 TC[Scopus]:7  IF:10.0/11.3 | Submit date：2024/02/22
Cancer Immunotherapy  Cyclic Gmp–amp Synthase-stimulator Of Interferon Gene Pathway  Melanoma  Photopyro  Pyroptosis  
GSH/pH Dual Activatable Cross-linked and Fluorinated PEI for Cancer Gene Therapy Through Endogenous Iron De-Hijacking and in Situ ROS Amplification Journal article
Yang, Suleixin, Wu, Yi, Zhong, Wenzhao, Chen, Ruie, Wang, Meilin, Chen, Meiwan. GSH/pH Dual Activatable Cross-linked and Fluorinated PEI for Cancer Gene Therapy Through Endogenous Iron De-Hijacking and in Situ ROS Amplification[J]. Advanced Materials, 2024, 36(2).
Authors:  Yang, Suleixin;  Wu, Yi;  Zhong, Wenzhao;  Chen, Ruie;  Wang, Meilin; et al.
Favorite | TC[WOS]:24 TC[Scopus]:22  IF:27.4/30.2 | Submit date：2024/02/22
Cancer Gene Therapy  Endogenous Iron De-hijacking  Ferroptosis  Lipid Peroxide  Mitochondria Damage  Reactive Oxygen Species  
Integrative analysis deciphers the heterogeneity of cancer-associated fibroblast and implications on clinical outcomes in ovarian cancers Journal article
Zhao, Yan, Mei, Song, Huang, Yixuan, Chen, Junru, Zhang, Xinlei, Zhang, Peng. Integrative analysis deciphers the heterogeneity of cancer-associated fibroblast and implications on clinical outcomes in ovarian cancers[J]. Computational and Structural Biotechnology Journal, 2022, 20, 6403-6411.
Authors:  Zhao, Yan;  Mei, Song;  Huang, Yixuan;  Chen, Junru;  Zhang, Xinlei; et al.
Favorite | TC[WOS]:13 TC[Scopus]:13  IF:4.4/5.0 | Submit date：2023/01/30
Bio-marker  Cafs  Gene Signature  Immunotherapy  Ovarian Cancer  Prognosis  Single-cell Sequencing  
A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing Review article
2022
Authors:  Xin-Zhu Chen;  Rong Guo;  Cong Zhao;  Jing Xu;  Hang Song; et al.
Favorite | TC[WOS]:11 TC[Scopus]:13  IF:4.4/5.0 | Submit date：2023/01/30
Anti-cancer Therapy  Crispr/cas9  Ethics  Gene Editing Technology  Off-target Effect  
Core promoter mutation contributes to abnormal gene expression in bladder cancer Journal article
Teng Huang, Jiaheng Li, San Ming Wang. Core promoter mutation contributes to abnormal gene expression in bladder cancer[J]. BMC Cancer, 2022, 22(1), 68.
Authors:  Teng Huang;  Jiaheng Li;  San Ming Wang
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:3.4/3.8 | Submit date：2022/05/13
Bladder Cancer  Core Promoter  Gene Expression  Mutation  
Targeting PLA2G16, a lipid metabolism gene, by Ginsenoside Compound K to suppress the malignant progression of colorectal cancer Journal article
Yang, Li, Zheng, Lingjie, Xie, Xiaonv, Luo, Junjia, Yu, Jing, Zhang, Lihua, Meng, Wenhui, Zhou, Yingen, Chen, Ling, Ouyang, Dongsheng, Zhou, Honghao, Tan, Zhirong. Targeting PLA2G16, a lipid metabolism gene, by Ginsenoside Compound K to suppress the malignant progression of colorectal cancer[J]. Journal of Advanced Research, 2021, 36, 265-276.
Authors:  Yang, Li;  Zheng, Lingjie;  Xie, Xiaonv;  Luo, Junjia;  Yu, Jing; et al.
Favorite | TC[WOS]:16 TC[Scopus]:17  IF:11.4/11.0 | Submit date：2022/03/04
Colorectal Cancer  Ginsenoside Compound k  Hippo Signaling Pathway  Lipid Metabolism Gene  Lipidomics  Pla2g16  
Upregulated expression of MMP family genes is associated with poor survival in patients with esophageal squamous cell carcinoma via regulation of proliferation and epithelial-mesenchymal transition Journal article
Xu, Guifeng, Ou, Ling, Liu, Ying, Wang, Xiao, Liu, Kaisheng, Li, Jieling, Li, Junjun, Wang, Shaoqi, Huang, Dane, Zheng, Kai, Wang, Shaoxiang. Upregulated expression of MMP family genes is associated with poor survival in patients with esophageal squamous cell carcinoma via regulation of proliferation and epithelial-mesenchymal transition[J]. Oncology Reports, 2020, 44(1), 29-42.
Authors:  Xu, Guifeng;  Ou, Ling;  Liu, Ying;  Wang, Xiao;  Liu, Kaisheng; et al.
Favorite | TC[WOS]:4 TC[Scopus]:7  IF:3.8/3.4 | Submit date：2021/12/06
Epithelial-mesenchymal Transition  Esophageal Squamous Cell Carcinoma  Gene Expression Omnibus  Matrix Metalloproteinase Family  Prognostic Value  The Cancer Genome Atlas  
Building potent chimeric antigen receptor T cells with CRISPR genome editing Journal article
Liu, J., Zhou, G., Zhang, L., Zhao, Q.. Building potent chimeric antigen receptor T cells with CRISPR genome editing[J]. Frontiers in Immunology, 2019, 456-456.
Authors:  Liu, J.;  Zhou, G.;  Zhang, L.;  Zhao, Q.
Favorite |   IF:5.7/6.8 | Submit date：2023/08/25
chimeric antigen receptor  CRISPR  gene editing  immunotherapy  cancer  CAR T